‘Why Don't We Get Counselling?’: Comparing NICE Guidelines for Morphological and Genetic Cancer Risk Diagnoses
Cancer Medicine · 2025
DOI: 10.1002/cam4.70607 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Cancer Medicine, 2025. Verfasst von Elspeth Davies. Beteiligte Einrichtung: Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK. Hauptthemen laut MEDLINE: Genetic Counseling, Practice Guidelines as Topic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: International Alliance for Cancer Early Detection.
Abstract (Originalsprache)
Background
In the UK's National Health Service (NHS), there is specific psychosocial care offered to people with genetic cancer risk conditions but not morphological cancer risk conditions. As researchers develop new ways to diagnose morphological risk conditions, including precancers and in situ cancers, it is important to consider the psychosocial care that those diagnosed might require.
Objectives
This study compares the National Institute for Health and Care Excellence's guidelines for BRCA1/2, which are genetic risk conditions, and Barrett's oesophagus (BO), a morphological risk condition. It then theorises reasons for the similarities and differences made visible by this comparative work.
Methods
The author completed an in‐depth analysis of two sets of NICE guidelines, before carrying out a review of historical and social scientific literature on cancer risk to offer potential explanations for the disparities identified.
Results
The ‘right not to know’ is protected in the case of BRCA1/2 diagnoses, but not BO. Additionally, specialist counselling is required for people receiving diagnoses of genetic risk but not offered for those diagnosed with morphological risk conditions. The paper offers four possible reasons for these disparities, concluding that they appear to be in large part due to historic genetic exceptionalism, rather than differences in patients' needs.
Conclusion
There may be a need to consider offering further psychosocial care to people with morphological risk conditions like BO. Lessons might be learnt from the field of genetic counselling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
ORCID-Profile: Elspeth Davies
Förderung
- International Alliance for Cancer Early Detection
Zitieren
APA
Davies, E. (2025). ‘Why Don't We Get Counselling?’: Comparing NICE Guidelines for Morphological and Genetic Cancer Risk Diagnoses. Cancer Medicine. https://doi.org/10.1002/cam4.70607
Vancouver
Davies E. ‘Why Don't We Get Counselling?’: Comparing NICE Guidelines for Morphological and Genetic Cancer Risk Diagnoses. Cancer Medicine. 2025. doi:10.1002/cam4.70607
BibTeX
@article{Davies2025,
author = {Davies, Elspeth},
title = {‘Why Don't We Get Counselling?’: Comparing NICE Guidelines for Morphological and Genetic Cancer Risk Diagnoses},
journal = {Cancer Medicine},
year = {2025},
doi = {10.1002/cam4.70607}
}
EUVIMED